Syneron Medical (ELOS) Posts Q2 non-GAAP Loss of $0.12, In-Line with Views
Syneron Medical Ltd. (Nasdaq: ELOS) reports Q2 non-GAAP loss of $0.12, even with the analyst estimate of ($0.12). Revenue for the quarter was $48.6 million, which compares to the estimate of $46.60 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intelligent Systems Corp. (INS) Intends to Explore Strategic Initiatives, Parties Interested in Major Subsidiaries
- ConAgra Foods (CAG) Reports In-Line Q2 EPS
- Winnebago Industries, Inc. (WGO) Misses Q1 EPS by 8c